X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2966) 2966
Newsletter (1736) 1736
Book Review (483) 483
Publication (157) 157
Book / eBook (31) 31
Newspaper Article (28) 28
Dissertation (27) 27
Magazine Article (22) 22
Reference (17) 17
Conference Proceeding (12) 12
Book Chapter (10) 10
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
myelocytic leukemia (2879) 2879
nonlymphoid leukemia (2775) 2775
research (1965) 1965
cancer (1943) 1943
index medicus (1928) 1928
humans (1858) 1858
oncology, experimental (1345) 1345
oncology (1053) 1053
hematology (1033) 1033
care and treatment (880) 880
genetic aspects (841) 841
reports (810) 810
universities and colleges (800) 800
male (796) 796
female (752) 752
adult (653) 653
chronic myelocytic-leukemia (653) 653
middle aged (642) 642
leukemia (597) 597
chronic myelogenous leukemia (559) 559
acute myelocytic-leukemia (510) 510
aged (492) 492
antineoplastic agents (421) 421
antimitotic agents (408) 408
analysis (407) 407
animals (347) 347
acute myelogenous leukemia (308) 308
prognosis (304) 304
adolescent (302) 302
apoptosis (300) 300
health aspects (293) 293
leukemia, myelogenous, chronic, bcr-abl positive - genetics (292) 292
acute myeloid-leukemia (290) 290
chronic myeloid-leukemia (287) 287
acute myeloid leukemia (272) 272
chronic myeloid leukemia (269) 269
hematopoietic stem cells (269) 269
transplantation (261) 261
chemotherapy (260) 260
acute lymphoblastic-leukemia (252) 252
stem cells (248) 248
abridged index medicus (244) 244
drug therapy (242) 242
risk factors (230) 230
leukemia, myelogenous, chronic, bcr-abl positive - pathology (225) 225
diagnosis (212) 212
mice (204) 204
development and progression (203) 203
acute nonlymphocytic leukemia (201) 201
drugs (201) 201
gene expression (197) 197
child (195) 195
treatment outcome (190) 190
philadelphia-chromosome (188) 188
acute myelocytic leukemia (183) 183
acute disease (179) 179
cells (178) 178
physiological aspects (177) 177
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (176) 176
antineoplastic agents - therapeutic use (174) 174
antineoplastic combined chemotherapy protocols - therapeutic use (174) 174
therapy (173) 173
leukemia, myeloid, acute - drug therapy (172) 172
aged, 80 and over (170) 170
bone marrow (169) 169
leukemia, myeloid, acute - genetics (168) 168
mutation (168) 168
medical research (162) 162
philadelphia chromosome (162) 162
genetics & heredity (160) 160
chronic myelocytic leukemia (158) 158
fusion proteins, bcr-abl - genetics (158) 158
remission induction (155) 155
myeloid leukemia (154) 154
imatinib mesylate (152) 152
cml (149) 149
phosphotransferases (149) 149
expression (147) 147
blast crisis (145) 145
bone-marrow transplantation (145) 145
colony-stimulating factor (144) 144
leukemia, myeloid, acute - pathology (142) 142
genes (141) 141
cell research (139) 139
medicine, general & internal (139) 139
cell biology (138) 138
chronic granulocytic-leukemia (137) 137
leukemia, myeloid - pathology (135) 135
biochemistry & molecular biology (133) 133
acute promyelocytic leukemia (132) 132
acute myeloblastic-leukemia (131) 131
aml (131) 131
hemic and lymphatic diseases (130) 130
scientists (130) 130
cytogenetics (129) 129
medicine & public health (126) 126
immunology (125) 125
leukemia, myeloid - genetics (123) 123
medicine, experimental (123) 123
cytarabine - administration & dosage (121) 121
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (19) 19
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Credit Valley Hospital - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4692) 4692
German (34) 34
Korean (23) 23
French (22) 22
Japanese (14) 14
Russian (14) 14
Spanish (14) 14
Italian (6) 6
Portuguese (5) 5
Chinese (3) 3
Polish (3) 3
Turkish (3) 3
Czech (1) 1
Danish (1) 1
Hungarian (1) 1
Persian (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2013, ISBN 1615190678, xiii, 303 p., [8] p. of plates
Book
2008, ISBN 3540723021, x, 294
Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. Thus, several... 
Leukemia, Myeloid, Acute | Precursor Cell Lymphoblastic Leukemia-Lymphoma
Book
2007, Contemporary hematology, ISBN 9781588296214, xiv, 426
Acute Myelogenous Leukemia is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of acute myelogenous leukemia (AML). The... 
Acute myeloid leukemia | Leukemia, Myelocytic, Acute | Clinical & internal medicine | Hematology | Oncology | Cancer Research | Internal Medicine | Medicine & Public Health
Book
2001, 1, ISBN 185317890X, xv, 528
In this volume, an international team of experts in chronic myeloid leukemia share their expertise. In particular, they contribute their insights on the latest... 
Treatment | Leukemia, Myeloid | Acute myeloid leukemia | therapy | Clinical & internal medicine | Acute myelocytic leukaemia | Hematology | Oncology | Acute myelocytic leukemia
Book
2011, 1. Aufl., ISBN 9781444393996, xxi, 416
This comprehensive book captures and compiles new and current information on hematologic malignancies. New knowledge of cellular disease processes, molecular... 
Leukemia, Lymphoid | Leukemia, Myeloid | Leukemia | therapy | Lymphomas | metabolism | Myelodysplastic syndromes
Book
1982, Praeger special studies. Praeger scientific, ISBN 0030600537, x, 251
Book
1999, Basic and clinical oncology, ISBN 9780824799014, Volume 16., xi, 442
Book
2010, 1, Cancer treatment and research, ISBN 0387692592, Volume 145., ix, 280
Acute myelogenous leukemia (AML) is the most common form of leukemia in adults and is a deadly form of malignancy. This book details the work of pioneers in... 
Gene therapy | Acute myeloid leukemia | Genetic aspects | Clinical & internal medicine | Oncology | Medicine & Public Health | Hematology
Book
2007, Current topics in microbiology and immunology, ISBN 9783540345923, Volume 313., vi, 273
Over the past 10 years, work on acute promyelocytic leukemia (APL) has become the paradigm of translational research that began with the discovery of a... 
Animal models | Treatment | Pathogenesis | Acute myeloid leukemia | Cancer Research | Biomedicine
Book
1987, ISBN 9780702012174, Volume 1/no. 4., x, p. 869-1080.
Book
1997, Baillière's clinical haematology, ISBN 9780702023439, Volume 10, no. 2., x, p. 187-428.
Book
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 5, pp. 454 - 464
Midostaurin, an oral multitargeted kinase inhibitor, is active in patients with a FLT3 mutation. Among patients with acute myeloid leukemia and this mutation,... 
TRIAL | INTERNAL TANDEM DUPLICATION | WILD-TYPE | MEDICINE, GENERAL & INTERNAL | FAVORABLE PROGNOSIS | ACUTE MYELOGENOUS LEUKEMIA | DISTINCT | TYROSINE KINASE INHIBITOR | SORAFENIB | PHASE-I | YOUNGER | Humans | Middle Aged | Kaplan-Meier Estimate | Staurosporine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Staurosporine - analogs & derivatives | Protein Kinase Inhibitors - adverse effects | Cytarabine - administration & dosage | Leukemia, Myeloid, Acute - mortality | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Mutation | Daunorubicin - administration & dosage | Leukemia, Myeloid, Acute - genetics | Staurosporine - administration & dosage | Chemotherapy | Care and treatment | Myelocytic leukemia | Nonlymphoid leukemia | Research | Drug therapy | Cancer | Tyrosine | Medical research | Inhibitor drugs | Myeloid leukemia | Leukemia | Clinical trials | Oncology | Transplantation | Kinases | Patients | Cancer therapies | Survival | Cytarabine | Daunorubicin | Medical prognosis | Point mutation | Death | Remission | Acute myeloid leukemia | Protein-tyrosine kinase | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 13, pp. 1249 - 1259
Patients with AML who were between 17 and 60 years of age were randomly assigned to receive induction therapy with the standard dose of daunorubicin or twice... 
CYTOSINE-ARABINOSIDE | MEDICINE, GENERAL & INTERNAL | ONCOLOGY-GROUP | INDUCTION CHEMOTHERAPY | ACUTE NONLYMPHOCYTIC LEUKEMIA | ACUTE MYELOGENOUS LEUKEMIA | ACUTE MYELOCYTIC-LEUKEMIA | GROUP-B | DAUNORUBICIN | REMISSION INDUCTION | UNTREATED ADULT PATIENTS | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Age Factors | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Leukemia, Myelomonocytic, Acute - drug therapy | Stem Cell Transplantation | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Leukemia, Myelomonocytic, Acute - therapy | Adult | Female | Remission Induction - methods | Daunorubicin - administration & dosage | Leukemia, Myelomonocytic, Acute - genetics | Histone-Lysine N-Methyltransferase | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Combined Modality Therapy | Cytarabine - administration & dosage | Daunorubicin - adverse effects | Antibiotics, Antineoplastic - administration & dosage | Myeloid-Lymphoid Leukemia Protein - genetics | Adolescent | Infusions, Intravenous | Mutation | Leukemia, Myelomonocytic, Acute - mortality | Anthracyclines | Usage | Daunorubicin | Young adults | Health aspects | Bone marrow | Chemotherapy | Consolidation | Kinases | Index Medicus | Abridged Index Medicus
Journal Article
Nature, ISSN 0028-0836, 10/2011, Volume 478, Issue 7370, pp. 524 - 528
Journal Article